Hostname: page-component-848d4c4894-p2v8j Total loading time: 0.001 Render date: 2024-05-29T02:40:40.915Z Has data issue: false hasContentIssue false

Recruitment Into a Cessation Trial Via the New Zealand Quitline: Many Benefits, Few Limitations

Published online by Cambridge University Press:  21 February 2012

Chris Bullen*
Affiliation:
Clinical Trials Research Unit, School of Population Health, University of Auckland, New Zealand. c.bullen@ctru.auckland.ac.nz
Colin Howe*
Affiliation:
Clinical Trials Research Unit, School of Population Health, University of Auckland, New Zealand.
Michele Grigg
Affiliation:
The Quit Group, Wellington, New Zealand.
Frances Phillips
Affiliation:
The Quit Group, Wellington, New Zealand.
Rose Silcock
Affiliation:
The Quit Group, Wellington, New Zealand.
Marewa Glover
Affiliation:
Auckland Tobacco Control Research Centre, School of Population Health, University of Auckland, New Zealand.
Hayden McRobbie*
Affiliation:
Clinical Trials Research Unit, School of Population Health, University of Auckland, New Zealand.
Robyn Whittaker*
Affiliation:
Clinical Trials Research Unit, School of Population Health, University of Auckland, New Zealand.
*
*Address for correspondence: Drs Bullen, Howe, McRobbie and Whittaker, Clinical Trials Research Unit, School of Population Health, University of Auckland, Private Bag 92019, Auckland 1072, New Zealand.
*Address for correspondence: Drs Bullen, Howe, McRobbie and Whittaker, Clinical Trials Research Unit, School of Population Health, University of Auckland, Private Bag 92019, Auckland 1072, New Zealand.
*Address for correspondence: Drs Bullen, Howe, McRobbie and Whittaker, Clinical Trials Research Unit, School of Population Health, University of Auckland, Private Bag 92019, Auckland 1072, New Zealand.
*Address for correspondence: Drs Bullen, Howe, McRobbie and Whittaker, Clinical Trials Research Unit, School of Population Health, University of Auckland, Private Bag 92019, Auckland 1072, New Zealand.

Abstract

Objective: To report on the use of the New Zealand Quitline for recruiting participants to a smoking cessation trial. Methods: Analysis of data on trial recruitment and randomisation. Results: 68% of 26,369 callers to the New Zealand Quitline over 12 months indicated an interest in taking part in research, 28% of whom met eligibility criteria for a cessation intervention trial, assessed on the data routinely collected at Quitline registration. Of these, 1317 (26%) were contacted by call back with 1027 (78%) agreeing to take part in the trial. After further eligibility checking 851 people were randomised. Weighting of calls ensured that 25% of participants were Maori. Conclusions: Quitlines have good potential to be an effective means of randomising participants into cessation trials and ensuring adequate representation of underrepresented population groups.

Type
Articles
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)